U.S. Vaccine Program Now Flush With Cash but Short on Key Details
Health
By Benjamin Mueller, Noah Weiland and Carl Zimmer from NYT Health https://ift.tt/1sX39NM
via IFTTT Vaccination and Immunization, Coronavirus (2019-nCoV), Regulation and Deregulation of Industry, Clinical Trials, your-feed-healthcare A $5 billion federal program aims to make better Covid vaccines. But vaccine makers are confused by murky regulatory guidance.

By Benjamin Mueller, Noah Weiland and Carl Zimmer from NYT Health https://ift.tt/1sX39NM
via IFTTT Vaccination and Immunization, Coronavirus (2019-nCoV), Regulation and Deregulation of Industry, Clinical Trials, your-feed-healthcare A $5 billion federal program aims to make better Covid vaccines. But vaccine makers are confused by murky regulatory guidance.
Comments
Post a Comment